Prenetics Global
About: Prenetics Global Ltd is a health sciences company dedicated to consumer and clinical health. Its consumer initiative is led by IM8, a new health and wellness brand, and Europa, a U.S. sports distribution company. The clinical division is led by Insighta, focused on multi-cancer early detection technologies. This is followed by ACT Genomics, which has achieved FDA clearance for genomic profiling of solid tumors, and CircleDNA, which uses NGS to offer DNA tests. Each Prenetics unit impacts health by 'enhancing life through science'.
Employees: 320
Fund manager confidence
Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)
14% more funds holding
Funds holding: 7 [Q2] → 8 (+1) [Q3]
0.75% less ownership
Funds ownership: 11.21% [Q2] → 10.45% (-0.75%) [Q3]
37% less capital invested
Capital invested by funds: $7.06M [Q2] → $4.47M (-$2.59M) [Q3]
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 2
Research analyst outlook
1 Wall Street Analyst provided 1 year price targets over the past 3 months
1 analyst rating
Cantor Fitzgerald Ross Osborn 50% 1-year accuracy 24 / 48 met price target | 55%upside $9 | Overweight Reiterated | 4 Dec 2024 |
Financial journalist opinion
Based on 3 articles about PRE published over the past 30 days